Skip to main content
Premium Trial:

Request an Annual Quote

Swiss Functional Genomics Center Licenses Rosetta s Resolver

NEW YORK, Nov. 21 (GenomeWeb News) - The Functional Genomics Center of Zurich, Switzerland, has licensed the Rosetta Resolver gene expression-analysis system, Rosetta said today.


The center will use the system to analyze and store cross-platform microarray data generated from its regional functional genomic projects.


The Rosetta Resolver is developed and supported by Rosetta Biosoftware and is distributed exclusively by Agilent Technologies. Rosetta Biosoftware is a business unit of Rosetta Inpharmatics, a wholly owned subsidiary of Merck.


Financial details were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.